Detalles de la búsqueda
1.
Activation of G proteins and extracellular signal-regulated kinase 1/2 phosphorylation via human dopamine D4.4 receptors: differential pathway-dependent potencies of receptor agonists.
Naunyn Schmiedebergs Arch Pharmacol
; 379(1): 87-99, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18682919
2.
Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Eur J Pharmacol
; 594(1-3): 32-8, 2008 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18703043
3.
Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
Naunyn Schmiedebergs Arch Pharmacol
; 376(1-2): 93-105, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17786406
4.
Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse model.
Pharmacol Res Perspect
; 4(2): e00214, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27069629
5.
Competitive interaction of 5-HT(1A) receptors with G-protein subtypes in CHO cells demonstrated by RNA interference.
Cell Signal
; 23(1): 58-64, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20727408
6.
Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
Eur J Pharmacol
; 640(1-3): 8-14, 2010 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20450907
Resultados
1 -
6
de 6
1
Próxima >
>>